Skip to main content

Table 1 Clinical characteristics of women with cervical insufficiency and control women

From: Whole blood RNA sequencing reveals a differential transcriptomic profile associated with cervical insufficiency: a pilot study

  CI group (n = 11) Controls (n = 4) P value CI-preterm group (n = 4) CI-term group (n = 7) P value
Maternal age (years) 34.0 (31.0–37.0) 32.0 (30.3–36.8) 0.66 35.0 (33.3–36.8) 33.0 (29.0–38.0) 0.79
Gestational age at blood collection (weeks) 19.4 (17.3–25.0) 23.0 (19.0–25.2) 0.41 17.8 (16.0–23.3) 21.1 (19.3–25.1) 0.23
Gestational age at delivery (weeks) 37.0 (21.2–38.1) 38.9 (38.2–39.9) 0.04 19.8 (17.4–30.9) 38.0 (37.0–39.0) < 0.01
Nulliparous, n (%) 4 (36.3) 1 (25.0) 1.00 2 (50.0) 2 (28.6) 0.58
WBC count (cell/mL) 8450 (6880-11,820)   12,275 (9293-13,878) 7010 (6540-9080) 0.02
Neutrophil count (cell/mL) 7120 (4620-10,080)   10,240 (8055-11,734) 4720 (4600-7120) 0.01
C-reactive protein (mg/L) 4.0 (3.2–5.8)    4.9 (3.4–15.9) 3.9 (2.8–5.5) 0.41
Cervical dilation, n (%)
 ≥ 3 cm 7 (63.6)   3 (75.0) 4 (57.1) 1.00
 < 3 cm 4 (36.4)   1 (25.0) 3 (42.9) 1.00
  1. CI Cervical insufficiency, WBC White blood cell